Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have been given a consensus rating of “Moderate Buy” by the thirteen research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $109.75.

A number of research firms recently commented on ALAB. Barclays lifted their price target on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a report on Friday. Roth Mkm lifted their target price on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating and increased their price target for the company from $100.00 to $120.00 in a research note on Thursday, January 2nd. Northland Capmk downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th.

Insider Buying and Selling

In other news, General Counsel Philip Mazzara sold 2,513 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.81, for a total transaction of $228,205.53. Following the completion of the transaction, the general counsel now directly owns 248,745 shares in the company, valued at approximately $22,588,533.45. This represents a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Michael Truett Tate sold 7,398 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $671,812.38. Following the sale, the chief financial officer now directly owns 286,424 shares in the company, valued at approximately $26,010,163.44. This trade represents a 2.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,690,452 shares of company stock worth $167,581,256 in the last ninety days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Strategic Blueprint LLC raised its position in Astera Labs by 3.6% during the 3rd quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock worth $298,000 after purchasing an additional 195 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after buying an additional 224 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Astera Labs by 5.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock worth $277,000 after acquiring an additional 284 shares during the last quarter. ORG Wealth Partners LLC acquired a new position in shares of Astera Labs in the fourth quarter worth approximately $42,000. Finally, Hollencrest Capital Management bought a new stake in Astera Labs in the third quarter valued at approximately $26,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $133.30 on Wednesday. The stock’s 50-day moving average is $119.56 and its 200-day moving average is $76.65. Astera Labs has a one year low of $36.22 and a one year high of $147.39.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs’s revenue for the quarter was up 47.1% compared to the same quarter last year. Equities research analysts expect that Astera Labs will post -0.45 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.